Prosecution Insights
Last updated: May 29, 2026

Examiner: CORNELIUS, CLAIRE ADRIENNE

Tech Center 1600 • Art Units: 1600 1632 1671 1672

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-60.0% vs TC avg
22
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

11.1%
§101 Eligibility
0%
§102 Novelty
66.7%
§103 Obviousness
14.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18031163 T-CELL VACCINE FOR SARS VIRUS Non-Final OA THE JOHNS HOPKINS UNIVERSITY
18269708 COMPOSITION FOR PREVENTION OR TREATMENT OF SARS-COV-2 INFECTION Final Rejection AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18301542 TREATMENT OF INFLAMMATORY CONDITIONS Non-Final OA Kyoto University
18038665 METHODS OF TREATING SARS-COV-2 INFECTIONS Non-Final OA HAMAD MEDICAL CORPORATION
18262073 Therapeutic Viral Vaccine Non-Final OA GlaxoSmithKline Biologicals SA
18493787 ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY Non-Final OA Joint BioScinces
18229010 LIPIDATED FLIPR AND USES THEREOF IN VACCINE Non-Final OA National Health Research Institutes
17928255 ADJUVANTS FOR SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS (SARS-COV) VACCINES Non-Final OA Children's Medical Center Corporation
18546690 INFLUENZA VIRUS DEFECTIVE INTERFERING PARTICLES FOR USE IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF CORONAVIRIDAE INFECTION Non-Final OA Otto-von-Guericke-Universität Magdeburg
18350357 FOAM VACCINATION OF AVIANS Non-Final OA UNIVERSITY OF DELAWARE
18030480 METHOD FOR DETECTION OF RNA OR DNA FROM BOLOGICAL SAMPLES Non-Final OA MATERIALS AND MACHINES CORPORATION OF AMERICA
18037226 MULTICISTRONIC RNA VACCINES AND USES THEREOF Non-Final OA SEQIRUS INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month